Are IVs safe
As always, it is crucial to consult with a qualified healthcare professional who can provide personalized recommendations based on individual health needs and goals
10.1038/tp.2013.51 10 FryeR
Virtually all PDP enrollees pay coinsurance for preferred brands (97%) and non-preferred drugs (100%)
Disclosure of interest: Anastasios Mavridis: Nothing to Disclose, Adam Viktorisson: Nothing to Disclose, Bjrn Eliasson: Nothing to Disclose, Mia von Euler: Nothing to Disclose, Katharina S Sunnerhagen: Nothing to Disclose Poster Session II - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P999 - ESOC25-160 PREDICTORS OF 90-DAY OUTCOMES AND HEMORRHAGIC RISK AFTER ENDOVASCULAR THROMBECTOMY WITH STENT RELEASE IN PATIENTS WITH ACUTE CAROTID ARTERY ATHEROSCLEROTIC ISCHEMIC STROKE Gaia Mignani 1 , Marta Del Chicca 1 , Nicola Giannini 1 , Marco Baldini 1 , Roberto D'agliano 1 , Alessandro Grigolini 2 , Giacomo Petrucci 2 , Filippo Baldacci 1 , Mirco Cosottini 2 1 Neurological Clinic, University of Pisa, Pisa, Italy, 2 Neuroradiology Unit, University of Pisa, Pisa, Italy Background and Aims: To investigate clinical and procedural factors associated with the 90-day modified Rankin Scale (mRS) and symptomatic intracranial hemorrhage (sICH) at 6 and 12 hours after endovascular thrombectomy (EVT) with carotid stent release
e421 Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al
